CDKN2A and melanoma: A few melanoma‐prone families, with no linkage to CDKN2A, have been found to carry PVs in CDK4 [3, 4, 5, 6], thus having alterations affecting the same cellular mechanism as CDKN2A, since p16INK4a is a direct inhibitor of CDK4 function [7].